Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reuters Events is a global business-to-business events organizer and a division of the international news organization Reuters, owned by Thomson Reuters. The company specializes in high-level conferences and exhibitions across various sectors, with a significant and dedicated focus on the pharmaceutical and healthcare industries. Through its pharma division, which integrated the well-known Eyeforpharma brand, it facilitates strategic networking and knowledge sharing among industry executives, regulators, and patient advocates. Its services include organizing large-scale summits, webinars, and providing industry-specific insights to help professionals navigate complex market landscapes such as clinical trials, commercialization, and digital health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reuters Events.